(Q41155350)

27 September 2017

1 reference

title

Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease (English)

1 reference

27 September 2017

1 reference

1

R N Brogden

1 reference

27 September 2017

P Benfield

2

1 reference

27 September 2017

publication date

1 May 1996

1 reference

27 September 2017

1 reference

27 September 2017

volume

51

1 reference

27 September 2017

issue

5

1 reference

27 September 2017

page(s)

792-819

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199651050-00007

27 September 2017

exact match

0 references

cites work

Reduction of creatine kinase and creatine kinase-MB indexes of infarct size by intravenous verapamil

1 reference

12 December 2020

Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris

1 reference

12 December 2020

The effects on left ventricular performance of nifedipine and verapamil in exercise-induced angina pectoris

1 reference

12 December 2020

Part I: pharmacologic and hemodynamic actions and interactions. Pharmacologic and hemodynamic mechanisms underlying the antianginal actions of verapamil

1 reference

12 December 2020

A double-blind randomized trial of propranolol and verapamil in the treatment of effort angina

1 reference

12 December 2020

Effects of long-term verapamil therapy on serum lipids and other metabolic parameters

1 reference

12 December 2020

Verapamil overdose: case report and review of the literature

1 reference

12 December 2020

Calcium Antagonists in Secondary Prevention after Myocardial Infarction

1 reference

12 December 2020

Evaluation of verapamil and high dose nifedipine in patients with chronic stable angina with objective methods

1 reference

12 December 2020

Stevens–Johnson syndrome induced by verapamil

1 reference

12 December 2020

Sustained-release and instant-release verapamil in treatment of angina pectoris

1 reference

12 December 2020

[The cardioprotective effect of verapamil in acute percutaneous transluminal coronary angioplasty]

1 reference

12 December 2020

Poisoning with anti-hypertensive drugs: calcium antagonists

1 reference

12 December 2020

Regression of atherosclerosis in cholesterol-fed rabbits: effects of fish oil and verapamil

1 reference

12 December 2020

Acute Toxic Effects of Sustained-Release Verapamil in Chronic Renal Failure

1 reference

12 December 2020

Secondary prevention of death and reinfarction with verapamil after an acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction

1 reference

12 December 2020

The molecular basis for the use of calcium antagonists in ischaemic heart disease

1 reference

12 December 2020

Use of cell culture for optimisation of direct antiatherogenic therapy with verapamil.

1 reference

12 December 2020

Sustained-release verapamil and nifedipine in exercise-induced angina pectoris

1 reference

12 December 2020

Pharmacokinetics of verapamil and norverapamil during long-term oral therapy

1 reference

12 December 2020

Treatment with verapamil during and after an acute myocardial infarction: a review based on the Danish Verapamil Infarction Trials I and II. The Danish Study Group on Verapamil in Myocardial Infarction

1 reference

12 December 2020

Verapamil in unstable angina pectoris: failure to demonstrate a relationship between efficacy and plasma levels

1 reference

12 December 2020

Failure of calcium channel blockers to improve ventricular relaxation in humans

1 reference

12 December 2020

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

1 reference

12 December 2020

The effects on left ventricular performance of verapamil and metoprolol singly and together in exercise-induced angina pectoris.

1 reference

12 December 2020

Double-blind, randomized, placebo-controlled comparison of propranolol and verapamil in the treatment of patients with stable angina pectoris

1 reference

12 December 2020

Ca2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells

1 reference

12 December 2020

Improved left ventricular performance during exercise with verapamil or nifedipine in patients with chronic stable angina

1 reference

12 December 2020

Myocardial protection with verapamil during ischaemia and reperfusion: dissociation between myocardial salvage and the degree of ATP depletion during ischaemia

1 reference

12 December 2020

Randomized, double-blind comparison of propranolol alone and a propranolol-verapamil combination in patients with severe angina of effort

1 reference

12 December 2020

Serum binding of nifedipine and verapamil in patients with ischaemic heart disease on monotherapy

1 reference

12 December 2020

Double-blind randomized crossover trial of verapamil and propranolol in chronic stable angina

1 reference

12 December 2020

Effects of Treatment with Verapamil SR and Captopril on the Lipid Profile of Hypertensive Patients

1 reference

12 December 2020

Efficacy and safety of verapamil in patients with angina pectoris after 1 year of continuous, high-dose therapy

1 reference

12 December 2020

1 reference

12 December 2020

The novel calcium antagonist Ro 40-5967 limits myocardial infarct size in the dog.

1 reference

12 December 2020

Acute verapamil toxicity in a patient with chronic toxicity: possible interaction with ceftriaxone and clindamycin

1 reference

12 December 2020

Verapamil-induced changes in digoxin kinetics and intraerythrocytic sodium concentration

1 reference

12 December 2020

Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris.

1 reference

12 December 2020

Verapamil and digoxin: their respective effects on atrial fibrillation and their interaction

1 reference

12 December 2020

Nifedipine compared with verapamil in unstable angina pectoris

1 reference

12 December 2020

Combined effects of halothane anesthesia and verapamil on systemic hemodynamics and left ventricular myocardial contractility in patients with ischemic heart disease

1 reference

12 December 2020

[Verapamil versus propranolol in stable effort angina. Randomized, crossed, double-blind study]

1 reference

12 December 2020

Comparative effects of verapamil and isradipine on steady-state digoxin kinetics

1 reference

12 December 2020

One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial

1 reference

12 December 2020

Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators

1 reference

12 December 2020

Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS)

1 reference

12 December 2020

Comparison of verapamil and propranolol therapy for angina pectoris at rest: a randomized, multiple-crossover, controlled trial in the coronary care unit

1 reference

12 December 2020

Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity

1 reference

12 December 2020

Effects of verapamil on coronary hemodynamic function and vasomobility relative to its mechanism of antianginal action.

1 reference

12 December 2020

Use of cultured atherosclerotic cells for investigation of antiatherosclerotic effects of anipamil and other calcium antagonists

1 reference

12 December 2020

Near-total reduction in verapamil bioavailability by rifampin. Electrocardiographic correlates

1 reference

12 December 2020

Massive ingestion of sustained-release verapamil with a concretion and bowel infarction

1 reference

12 December 2020

Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia

1 reference

12 December 2020

Tolerability of combined treatment with verapamil and beta-blockers in angina resistant to monotherapy

1 reference

12 December 2020

Review of postinfarct treatment with verapamil: combined experience of early and late intervention studies with verapamil in patients with acute myocardial infarction. Danish Study Group on Verapamil in Myocardial Infarction

1 reference

12 December 2020

Verapamil-associated Stevens-Johnson syndrome

1 reference

12 December 2020

Effect of verapamil on serum lipoproteins in patients with angina pectoris

1 reference

12 December 2020

Elective response to propranolol or verapamil in ischemia on effort

1 reference

12 December 2020

Vascular protection from atherosclerosis: potential of calcium antagonists

1 reference

12 December 2020

Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium

1 reference

12 December 2020

Effects of verapamil on left ventricular relaxation and filling dynamics in coronary artery disease: a study by pulsed Doppler echocardiography

1 reference

12 December 2020

Verapamil in acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction

1 reference

12 December 2020

Long-term effects of verapamil on aortic smooth muscle cells cultured in the presence of hypercholesterolemic serum

1 reference

12 December 2020

Circadian variation in the pharmacokinetics of verapamil

1 reference

12 December 2020

Verapamil hydrochloride: pharmacological properties and role in cardiovascular therapeutics

1 reference

12 December 2020

Verapamil or propranolol in the treatment of stable angina pectoris of effort

1 reference

12 December 2020

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

1 reference

12 December 2020

Progression and regression by verapamil of vitamin D3-induced calcific medial degeneration in coronary arteries of rats

1 reference

12 December 2020

Oral verapamil inhibits platelet thrombus formation in humans

1 reference

12 December 2020

Effect of coadministration of verapamil and quinidine on serum digoxin concentration

1 reference

12 December 2020

Verapamil Administered Twice Daily in Stable Angina Pectoris

1 reference

12 December 2020

Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris

1 reference

12 December 2020

Requirements for drug monitoring of verapamil: experience from an unselected group of patients with cardiovascular disease

1 reference

12 December 2020

Effects of intravenous verapamil on left ventricular relaxation and filling in stable angina pectoris

1 reference

12 December 2020

Comparative effects of propranolol and verapamil alone and in combination on left ventricular function and volumes in patients with chronic exertional angina: a double-blind, placebo-controlled, randomized, crossover study with radionuclide ventricu

1 reference

12 December 2020

The influence of antituberculosis drugs on the plasma level of verapamil

1 reference

12 December 2020

Reduction of myocardial injury with verapamil before aortic cross-clamping

1 reference

12 December 2020

Massive verapamil ingestion: a report of two cases and a review of the literature

1 reference

12 December 2020

Bisoprolol in the treatment of angina pectoris: a double blind comparison with verapamil

1 reference

12 December 2020

Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris

1 reference

12 December 2020

The effect of diltiazem on mortality and reinfarction after myocardial infarction

1 reference

12 December 2020

Randomized placebo-controlled comparative study of nifedipine, verapamil and isosorbide dinitrate in the treatment of angina at rest

1 reference

12 December 2020

The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

1 reference

12 December 2020

Propranolol v. verapamil in the treatment of unstable angina. A double-blind cross-over study

1 reference

12 December 2020

Mechanism of relief of pacing induced angina with oral verapamil: reduced oxygen demand

1 reference

12 December 2020

Efficacy of conventional and sustained-release verapamil in stable angina pectoris

1 reference

12 December 2020

Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: a placebo-controlled, double-blind, randomized, crossover study

1 reference

12 December 2020

The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review

1 reference

12 December 2020

Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm following ptca

1 reference

12 December 2020

The acute hemodynamic effects of intravenous verapamil in coronary artery disease. Assessment by equilibrium-gated radionuclide ventriculography

1 reference

12 December 2020

Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research Group

1 reference

12 December 2020

Sustained release verapamil, a once daily preparation: objective evaluation using exercise testing, ambulatory monitoring and blood levels in patients with stable angina

1 reference

12 December 2020

Results of repeat angiography up to eight years following percutaneous transluminal angioplasty

1 reference

12 December 2020

Verapamil in acute myocardial infarction. Danish Multicenter Study Group on Verapamil in Myocardial Infarction

1 reference

12 December 2020

Treatment of transient myocardial ischemia in patients with stable angina: a comparative study of verapamil slow-release and nifedipine plus propranolol

1 reference

12 December 2020

Infarct size-limiting properties of Ro 40-5967, a novel nondihydropyridine calcium channel, in anesthetized rats: comparison with verapamil

1 reference

12 December 2020

Verapamil intoxication: a literature review of overdoses and discussion of therapeutic options

1 reference

12 December 2020

Verapamil: full spectrum calcium channel blocking agent: an overview

1 reference

12 December 2020

Electrocardiographic evaluation of anti-ischemic effect of verapamil during angioplasty

1 reference

12 December 2020

Effects of calcium antagonists on infarcting myocardium

1 reference

12 December 2020

Verapamil versus propranolol for angina at rest

1 reference

12 December 2020

Lipid Profile during Antihypertensive Treatment

1 reference

12 December 2020

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview

1 reference

12 December 2020

Treatment of silent ischemia in unstable angina: a randomized comparison of sustained-release verapamil versus metoprolol

1 reference

12 December 2020

Effects of beta-blockers and calcium channel blockers in acute myocardial infarction

1 reference

12 December 2020

Alteplase. A reappraisal of its pharmacological properties and therapeutic use in acute myocardial infarction

1 reference

12 December 2020

The prognostic significance of post-infarction angina pectoris and the effect of verapamil on the incidence of angina pectoris and prognosis. The Danish Study Group on Verapamil in Myocardial Infarction

1 reference

12 December 2020

In vitro models of anti-atherosclerotic effects of cardiovascular drugs

1 reference

12 December 2020

Treatment of stable angina of effort with verapamil: a double-blind, placebo-controlled randomized crossover study

1 reference

12 December 2020

Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis

1 reference

12 December 2020

Secondary Prevention with Calcium Antagonists after Acute Myocardial Infarction

1 reference

12 December 2020

Effect of verapamil on postischemic "stunned" myocardium: importance of the timing of treatment

1 reference

12 December 2020

Reperfusion injury in ischemic myocardium: effects of nifedipine and verapamil

1 reference

12 December 2020

Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbit

1 reference

12 December 2020

Secondary prevention with verapamil after myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction

1 reference

12 December 2020

Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension

1 reference

12 December 2020

Cardiovascular drugs and atherosclerosis: effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of verapamil following sublingual and oral administration to healthy volunteers

1 reference

12 December 2020

Prevalence of transient myocardial ischaemia during the first year after a myocardial infarction. Effect of treatment with verapamil. The Danish Study Group on Verapamil in Myocardial Infarction

1 reference

12 December 2020

Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry

1 reference

12 December 2020

Asystole and cardiogenic shock due to combined treatment with verapamil and flecainide

1 reference

12 December 2020

Effects of bepridil on regional myocardial ischemia and comparison with verapamil

1 reference

12 December 2020

Case report: sustained-release verapamil overdose causing stroke: an unusual complication

1 reference

12 December 2020

Treatment with verapamil after an acute myocardial infarction. Review of the Danish studies on verapamil in myocardial infarction (DAVIT I and II).

1 reference

12 December 2020

Secondary prevention reinfarction Israeli nifedipine trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. The Israeli Sprint Study Group

1 reference

12 December 2020

Incidence of adverse events during treatment with verapamil for suspected acute myocardial infarction

1 reference

12 December 2020

Effects of verapamil on myocardial performance in coronary disease

1 reference

12 December 2020

Calcium antagonists. Clinical use in the treatment of angina

1 reference

12 December 2020

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

1 reference

12 December 2020

Comparison of nicardipine and verapamil in the management of chronic stable angina

1 reference

12 December 2020

Long-Term Persistence of Antianginal Effect of Oral Verapamil in Chronic Stable Angina

1 reference

12 December 2020

Verapamil-induced secondary erythermalgia

1 reference

12 December 2020

Low-dose verapamil in middle-aged and elderly patients with angina pectoris: no evidence of increased susceptibility to the cardiac effects

1 reference

12 December 2020

Does verapamil limit myocardial infarct size in a heart deficient in xanthine oxidase?

1 reference

12 December 2020

The clinical use of verapamil.

1 reference

12 December 2020

Effect of calcium channel blocking agents on infarct size after ischaemia-reperfusion in anaesthetised pigs: relationship between cardioprotection and cardiodepression.

1 reference

12 December 2020

Bepridil versus verapamil in stable angina pectoris--a controlled clinical trial

1 reference

12 December 2020

Propranolol-verapamil versus propranolol-nifedipine in severe angina pectoris of effort: a randomized, double-blind, crossover study

1 reference

12 December 2020

Beta blockers and verapamil: a cautionary tale

1 reference

12 December 2020

Hypotension after quinidine plus verapamil. Possible additive competition at alpha-adrenergic receptors

1 reference

12 December 2020

Equal anti-ischemic properties of isosorbide dinitrate plus verapamil and isosorbide dinitrate plus propranolol. A randomized, double-blind and crossover study

1 reference

12 December 2020

Efficacy of sustained-release verapamil in chronic stable angina pectoris

1 reference

12 December 2020

Long-term results with verapamil in essential hypertension and its influence on serum lipids.

1 reference

12 December 2020

[Cross-over double-blind study of verapamil versus diltiazem in effort myocardial ischemia]

1 reference

12 December 2020

Differentiation between calcium- and cholesterol-dominated types of arteriosclerotic lesions: antiarteriosclerotic aspects of calcium antagonists

1 reference

12 December 2020

Intracoronary verapamil for reversal of refractory coronary vasospasm during percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Verapamil-rifampin interaction.

1 reference

12 December 2020

Combined therapy with Ca-antagonists and beta-adrenergic receptor blocking agents in chronic stable angina

1 reference

12 December 2020

Effects of quinidine, verapamil and nifedipine on the pharmacokinetics and pharmacodynamics of digitoxin during steady state conditions

1 reference

12 December 2020

Digoxin-verapamil interaction: reduction of biliary but not renal digoxin clearance in humans

1 reference

12 December 2020

The long-term treatment of stable angina pectoris with verapamil

1 reference

12 December 2020

Bepridil in stable angina of effort: a double-blind comparison with verapamil

1 reference

12 December 2020

Occlusion and reperfusion-induced arrhythmias in rats: involvement of platelets and effects of calcium antagonists

1 reference

12 December 2020

Randomized Double-Blind Comparison of the Effects of Isosorbide Dinitrate Retard, Verapamil Sustained-Release, and Their Combination on Myocardial Ischemic Episodes

1 reference

12 December 2020

A comparison of sustained release verapamil versus atenolol for 24 h protection from exercise-induced angina pectoris

1 reference

12 December 2020

Superiority of verapamil to propranolol in stable angina pectoris: a double-blind, randomized crossover trail

1 reference

12 December 2020

Effect of verapamil on left ventricular function: A randomized, placebo-controlled study

1 reference

12 December 2020

Calcium antagonism and norepinephrine release in myocardial ischemia

1 reference

12 December 2020

Comparative Efficacy, Safety and Pharmacokinetics of VErapamil SR vs VErapamil IR in Hypertensive Patients

1 reference

12 December 2020

Myocardial catecholamine balance during angina: effects of calcium entry blockers, verapamil and nifedipine

1 reference

12 December 2020

Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis

1 reference

12 December 2020

Verapamil toxicity--treatment with hemoperfusion

1 reference

12 December 2020

Antianginal and myocardial metabolic properties of verapamil in coronary artery disease

1 reference

12 December 2020

Pharmacologic effects on coronary microvessels during myocardial ischaemia

1 reference

12 December 2020

Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment

1 reference

12 December 2020

Variation of serum lipoproteins in postmyocardial infarction patients treated with verapamil or placebo

1 reference

12 December 2020

Aging alters verapamil elimination and dynamics: single dose and steady-state responses.

1 reference

12 December 2020

A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris

1 reference

12 December 2020

Frequency and importance of unprovoked coronary spasm in patients with angina pectoris undergoing percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Erythema multiforme after verapamil treatment

1 reference

12 December 2020

10.2165/00003495-199651050-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

27 September 2017

1046626751

0 references

1 reference